Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Alkermes, Ark, Bioarctic, Biogen, Biosplice, Cellenkos, Eisai, GSK, Johnson & Johnson, Milestone, Oculis, Zai Lab.

Biopharma happenings, including deals and partnerships, and other news in brief: Astrazeneca, Boehringer Ingelheim, Bostongene, Cartography, Convergent, Day One, Galapagos, Gasherbrum, Genentech, Gilead, Factor, Immuneonco, Instil, Lineage Cell, Mersana, Northstar Medical Radioisotopes, Onconano, Pfizer, Variant.

Clinical updates, including data readouts and publications: Aclaris, Actuate, Alumis, Apogee, Arrowhead, Astrazeneca, Bright Minds, Cognition, Compass, Demerx, Encellin, Huyabio, Idorsia, Iksuda, Johnson & Johnson, Metavia, Nanjing Delova, Novabridge, Seres.

Biopharmas raising money in public or private financings, including: IGC.

New hires and promotions in the biopharma industry, including: Alloy, Alvotech, Artbio, Atsena, Biolojic, Compass, Fractyl, Galecto, LB, Mezzion, Nanology, Outlook, Remix, Repligen, Splicebio, Spyglass, Syncromune.

New hires and promotions in the med-tech industry, including: Archeus Technologies, Capstan Medical, Dexcom, Forj Medical, GE Healthcare, Insight Molecular Diagnostics, Next Gen Diagnositics, Radnet, Sensus, Surgibox, Tolion, Truvian, Viz.ai, Vygon.

Med-tech firms raising money in public or private financings, including: Alpha Aesthetics Partners, Corsera, Imvaria, Spiro Medical Inc.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sera Prognostics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cairn Surgical, CSA Medical, Cordica Medical, J&J, Sophia Genetics, Team Technologies.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Altimmune, GH Research, GSK, Humacyte, Idorsia, Kelun-Biotech, Maplight, Moderna, Protagonist, Sanofi, Scinopharm, Takeda.